|Articles|May 3, 2017
George Clinical Acquires Vector Oncology
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division.
Advertisement
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division. This acquisition aims to assist George Clinical in providing oncology trial delivery solutions throughout the Asia-Pacific region.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
2025 Veeva R&D and Quality Summit: Advancing Site Efficiency and Collaboration in the Next Era of Clinical Trials
3
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
4
ACT Brief: Governance-Driven eCOA Acceleration, Site Operations Innovation, and New Momentum for Earlier CAR-T
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
